as on January 28, 2026 at 9:33 pm IST
Day's Low
Day's High
2.40%
Downside
1.54%
Upside
52 Week's Low
52 Week's High
49.49%
Downside
19.21%
Upside
Check Foghorn Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$340.4M
EPS (TTM)
-1.1056
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.05
Industry PE ratio
-1.8136016949152542
PEG Ratio
0EBITDA
-83.2M
Revenue (TTM)
24.5M
Profit Margin
-294.16%
Return On Equity TTM
-470.38%
Track how Foghorn Therapeutics Inc P/E has moved over time to understand its valuation trends.
Foghorn Therapeutics Inc in the last 5 years
Lowest (-5.46x)
December 31, 2025
Today (-5.05x)
January 28, 2026
Industry (-1.81x)
January 28, 2026
Highest (-1.75x)
June 30, 2021
Today’s Price to Earnings Ratio: -5.05x
Compare market cap, revenue, PE, and other key metrics of Foghorn Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $340.4M | -64.52% | -5.05 | -294.16% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
The Foghorn Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Foghorn Therapeutics Inc investment value today
Current value as on today
₹1,48,169
Returns
₹48,169
(+48.17%)
Returns from Foghorn Therapeutics Inc Stock
₹42,195 (+42.2%)
Dollar Returns*
₹5,974 (+5.97%)
Based on 11 analysts
81.82%
Buy
18.18%
Hold
0.00%
Sell
Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Foghorn Therapeutics Inc. Average target price of $11.67
Get share price movements and forecasts by analysts on Foghorn Therapeutics Inc.
What analysts predicted
50.04%UPSIDE
Target Price
$11.67
Current Price
$5.83
Analyzed by
11 Analysts
Target
$11.67
Foghorn Therapeutics Inc target price $11.67, a slight upside of 50.04% compared to current price of $5.83. According to 11 analysts rating.
Search interest for Foghorn Therapeutics Inc Stock has increased by 12% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:12% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 4 quarters, 2.85M → 8.15M (in $), with an average increase of 26.9% per quarter
Price Rise
![]()
In the last 3 months, FHTX stock has moved up by 32.6%
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -19.50M → -15.84M (in $), with an average increase of 7.2% per quarter
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 60.1%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 48.3% return, outperforming this stock by 4.4%
| Organisation | Foghorn Therapeutics Inc |
| Headquarters | 500 Technology Square, Cambridge, MA, United States, 02139 |
| Industry | Health Technology |
| CEO | Mr. Adrian H. B. Gottschalk |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Adrian H. B. Gottschalk | President, CEO & Director |
Dr. Anna Rivkin Ph.D. | Chief Business Officer |
Dr. Steven F. Bellon Ph.D. | Chief Scientific Officer |
Ms. Karin Hellsvik | Chief of Staff to the CEO, VP of Corporate Affairs & Investor Relations |
Mr. Carlos Costa | Chief People Officer |
Dr. Gerald R. Crabtree M.d. | Founder & Member of Scientific Advisory Board |
Mr. Jeffrey A. Sacher M.B.A. | Interim CFO & Treasurer |
Mr. Michael J. LaCascia J.D. | Chief Legal Officer |
Mr. Saurabh Sewak Ph.D. | Vice President of Corporate Development |
Dr. Alfonso Quintas Cardama M.D. | Chief Medical Officer |
Foghorn Therapeutics Inc share price today is $5.83 as on . Foghorn Therapeutics Inc share today touched a day high of $5.92 and a low of $5.69.
Foghorn Therapeutics Inc share touched a 52 week high of $6.95 on and a 52 week low of $2.94 on . Foghorn Therapeutics Inc stock price today i.e. is trending at $5.83,which is 16.12% down from its 52 week high and 97.98% up from its 52 week low.
Foghorn Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Foghorn Therapeutics Inc (FHTX) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in Foghorn Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Foghorn Therapeutics Inc share’s latest price of $5.83 as on January 28, 2026 at 9:33 pm IST, you will get 1.7153 shares of Foghorn Therapeutics Inc. Learn more about
fractional shares .
Foghorn Therapeutics Inc stock has given -64.52% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?